Microba Inventory vs Common Stock Analysis

MAP Stock

0.19 0.01 5.56%

Microba Life financial indicator trend analysis is infinitely more than just investigating Microba Life Sciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microba Life Sciences is a good investment. Please check the relationship between Microba Life Inventory and its Common Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Inventory vs Common Stock

Inventory vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microba Life Sciences Inventory account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between Microba Life's Inventory and Common Stock is 0.76. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Common Stock in the same time period over historical financial statements of Microba Life Sciences, assuming nothing else is changed. The correlation between historical values of Microba Life's Inventory and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Microba Life Sciences are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Inventory i.e., Microba Life's Inventory and Common Stock go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Inventory

Common Stock

Most indicators from Microba Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microba Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Microba Life's Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 19.6 M in 2024, whereas Tax Provision is likely to drop 4,690 in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	8.3K	60.4K	69.2K	40.8K
Depreciation And Amortization	1.5M	1.6M	2.9M	1.7M

Interest Expense Depreciation And Amortization

Microba Life fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.96	0.84	0.87	0.99	0.95	0.83	-0.85	-0.92	0.86	0.86	0.7	0.62	0.86	0.91	0.85	0.21	0.68	0.74	0.73	0.84	0.94	0.98	0.73	1.0	0.94
Short Long Term Debt Total	0.96		0.76	0.84	0.95	0.98	0.89	-0.81	-0.87	0.8	0.83	0.68	0.6	0.83	0.87	0.79	0.43	0.68	0.7	0.55	0.81	0.89	0.98	0.7	0.95	0.99
Other Current Liab	0.84	0.76		0.98	0.8	0.78	0.68	-0.62	-0.97	0.99	0.63	0.9	0.85	0.63	0.96	0.91	-0.1	0.87	0.94	0.79	0.97	0.74	0.83	0.93	0.86	0.68
Total Current Liabilities	0.87	0.84	0.98		0.84	0.84	0.79	-0.67	-0.99	0.97	0.68	0.92	0.87	0.68	0.97	0.89	0.06	0.9	0.95	0.71	0.99	0.78	0.88	0.94	0.89	0.77
Total Stockholder Equity	0.99	0.95	0.8	0.84		0.92	0.82	-0.91	-0.89	0.84	0.92	0.64	0.55	0.92	0.9	0.79	0.26	0.62	0.68	0.72	0.8	0.97	0.96	0.68	0.98	0.94
Property Plant And Equipment Net	0.95	0.98	0.78	0.84	0.92		0.81	-0.71	-0.87	0.82	0.73	0.76	0.7	0.73	0.87	0.88	0.39	0.76	0.76	0.51	0.84	0.82	0.96	0.77	0.93	0.96
Current Deferred Revenue	0.83	0.89	0.68	0.79	0.82	0.81		-0.76	-0.83	0.66	0.77	0.59	0.52	0.77	0.75	0.61	0.3	0.59	0.65	0.52	0.75	0.82	0.9	0.6	0.85	0.83
Net Debt	-0.85	-0.81	-0.62	-0.67	-0.91	-0.71	-0.76		0.73	-0.66	-1.0	-0.39	-0.27	-1.0	-0.77	-0.47	-0.36	-0.36	-0.43	-0.65	-0.6	-0.98	-0.82	-0.42	-0.82	-0.84
Retained Earnings	-0.92	-0.87	-0.97	-0.99	-0.89	-0.87	-0.83	0.73		-0.96	-0.74	-0.88	-0.82	-0.74	-0.98	-0.89	-0.07	-0.86	-0.92	-0.75	-0.98	-0.84	-0.92	-0.9	-0.93	-0.81
Accounts Payable	0.86	0.8	0.99	0.97	0.84	0.82	0.66	-0.66	-0.96		0.67	0.9	0.84	0.67	0.99	0.91	0.02	0.87	0.92	0.75	0.96	0.77	0.85	0.92	0.88	0.75
Cash	0.86	0.83	0.63	0.68	0.92	0.73	0.77	-1.0	-0.74	0.67		0.4	0.29	1.0	0.78	0.49	0.37	0.38	0.44	0.65	0.61	0.98	0.84	0.44	0.84	0.86
Non Current Assets Total	0.7	0.68	0.9	0.92	0.64	0.76	0.59	-0.39	-0.88	0.9	0.4		0.99	0.4	0.85	0.9	0.05	1.0	0.99	0.48	0.96	0.52	0.7	1.0	0.72	0.61
Non Currrent Assets Other	0.62	0.6	0.85	0.87	0.55	0.7	0.52	-0.27	-0.82	0.84	0.29	0.99		0.29	0.78	0.87	0.02	0.99	0.98	0.4	0.92	0.41	0.62	0.98	0.64	0.52
Cash And Short Term Investments	0.86	0.83	0.63	0.68	0.92	0.73	0.77	-1.0	-0.74	0.67	1.0	0.4	0.29		0.78	0.49	0.37	0.38	0.44	0.65	0.61	0.98	0.84	0.44	0.84	0.86
Net Receivables	0.91	0.87	0.96	0.97	0.9	0.87	0.75	-0.77	-0.98	0.99	0.78	0.85	0.78	0.78		0.87	0.13	0.83	0.88	0.75	0.95	0.86	0.91	0.88	0.92	0.83
Common Stock Shares Outstanding	0.85	0.79	0.91	0.89	0.79	0.88	0.61	-0.47	-0.89	0.91	0.49	0.9	0.87	0.49	0.87		-0.03	0.88	0.9	0.65	0.91	0.64	0.83	0.91	0.86	0.73
Long Term Debt Total	0.21	0.43	-0.1	0.06	0.26	0.39	0.3	-0.36	-0.07	0.02	0.37	0.05	0.02	0.37	0.13	-0.03		0.1	-0.03	-0.43	0.07	0.27	0.26	0.04	0.14	0.52
Non Current Liabilities Total	0.68	0.68	0.87	0.9	0.62	0.76	0.59	-0.36	-0.86	0.87	0.38	1.0	0.99	0.38	0.83	0.88	0.1		0.98	0.41	0.95	0.49	0.68	0.99	0.69	0.6
Inventory	0.74	0.7	0.94	0.95	0.68	0.76	0.65	-0.43	-0.92	0.92	0.44	0.99	0.98	0.44	0.88	0.9	-0.03	0.98		0.58	0.98	0.57	0.74	0.99	0.76	0.61
Other Current Assets	0.73	0.55	0.79	0.71	0.72	0.51	0.52	-0.65	-0.75	0.75	0.65	0.48	0.4	0.65	0.75	0.65	-0.43	0.41	0.58		0.64	0.74	0.68	0.52	0.77	0.49
Total Liab	0.84	0.81	0.97	0.99	0.8	0.84	0.75	-0.6	-0.98	0.96	0.61	0.96	0.92	0.61	0.95	0.91	0.07	0.95	0.98	0.64		0.72	0.84	0.97	0.86	0.74
Total Current Assets	0.94	0.89	0.74	0.78	0.97	0.82	0.82	-0.98	-0.84	0.77	0.98	0.52	0.41	0.98	0.86	0.64	0.27	0.49	0.57	0.74	0.72		0.92	0.56	0.92	0.9
Short Term Debt	0.98	0.98	0.83	0.88	0.96	0.96	0.9	-0.82	-0.92	0.85	0.84	0.7	0.62	0.84	0.91	0.83	0.26	0.68	0.74	0.68	0.84	0.92		0.72	0.98	0.95
Intangible Assets	0.73	0.7	0.93	0.94	0.68	0.77	0.6	-0.42	-0.9	0.92	0.44	1.0	0.98	0.44	0.88	0.91	0.04	0.99	0.99	0.52	0.97	0.56	0.72		0.75	0.63
Common Stock	1.0	0.95	0.86	0.89	0.98	0.93	0.85	-0.82	-0.93	0.88	0.84	0.72	0.64	0.84	0.92	0.86	0.14	0.69	0.76	0.77	0.86	0.92	0.98	0.75		0.91
Property Plant Equipment	0.94	0.99	0.68	0.77	0.94	0.96	0.83	-0.84	-0.81	0.75	0.86	0.61	0.52	0.86	0.83	0.73	0.52	0.6	0.61	0.49	0.74	0.9	0.95	0.63	0.91

Click cells to compare fundamentals

Microba Life Account Relationship Matchups

Microba Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.8M	18.5M	39.5M	47.0M	58.0M	34.4M
Short Long Term Debt Total	563.6K	269.0K	1.3M	1.1M	1.6M	968.7K
Other Current Liab	988.1K	1.7M	1.1M	3.9M	5.3M	5.5M
Total Current Liabilities	2.8M	3.4M	5.3M	7.8M	12.4M	13.0M
Total Stockholder Equity	7.7M	14.9M	33.5M	38.6M	41.2M	27.2M
Property Plant And Equipment Net	1.6M	1.2M	2.8M	2.6M	3.9M	2.5M
Current Deferred Revenue	1.1M	1.1M	2.6M	1.3M	2.2M	1.6M
Net Debt	(6.3M)	(12.8M)	(29.3M)	(30.9M)	(19.3M)	(20.3M)
Retained Earnings	(12.2M)	(19.7M)	(31.2M)	(43.9M)	(63.8M)	(60.6M)
Accounts Payable	392.3K	353.5K	813.2K	3.0M	3.7M	3.9M
Cash	6.9M	13.0M	30.6M	32.0M	20.9M	21.0M
Non Current Assets Total	2.7M	2.3M	3.7M	5.4M	25.8M	27.1M
Cash And Short Term Investments	6.9M	13.0M	30.6M	32.0M	20.9M	21.0M
Net Receivables	622.8K	376.3K	3.4M	7.2M	8.1M	8.5M
Long Term Debt Total	245.4K	66.8K	483.8K	234.1K	269.2K	287.6K
Liabilities And Stockholders Equity	10.8M	18.5M	39.5M	47.0M	58.0M	34.4M
Non Current Liabilities Total	260.6K	110.4K	678.6K	404.1K	4.5M	4.7M
Inventory	340.8K	513.3K	360.0K	644.4K	2.2M	2.4M
Other Current Assets	244.6K	1.0M	204.4K	1.6M	1.0M	781.9K
Other Stockholder Equity	622.9K	1.2M	78.2K	2.1M	2.4M	2.5M
Total Liab	3.1M	3.5M	5.9M	8.2M	16.8M	17.7M
Total Current Assets	8.1M	16.2M	35.8M	41.5M	32.2M	26.7M
Accumulated Other Comprehensive Income	622.9K	1.2M	1.9M	2.1M	2.2M	1.5M
Cash And Equivalents	49.8K	50.3K	204.4K	12.4M	14.3M	15.0M
Short Term Debt	318.2K	202.3K	841.4K	901.7K	1.2M	660.2K
Intangible Assets	118.7K	246.3K	853.9K	2.8M	13.4M	14.1M
Common Stock	19.3M	33.5M	62.9M	80.4M	102.9M	58.1M
Property Plant Equipment	1.6M	1.2M	2.8M	2.6M	3.0M	2.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microba Stock Analysis

When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC